Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alseres Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: john e vanden biesen who wrote (639)	2/17/1999 10:40:00 AM
From: Bobby Berry	Respond to of 975

Dilution John Dilution. Hope your right and that I am wrong.

To: john e vanden biesen who wrote (639)	2/17/1999 12:23:00 PM
From: J.S.	Read Replies (1) \| Respond to of 975

I have been lurking on the Yahoo thread and find the goings on there to be disturbing. All the hype and supposed insider information -- stock to be double digits by Friday etc -- presumably while negotiations were going on in the financing. Josephthal does not have a stellar reputation judging from my personal contacts. It is disturbing yet perhaps not surprising that they would permit these sorts of shenanigans. For those who are new to these sorts of financing deals. The problems are two fold. 1) Dilution 2)Pump and dump techniques so that the debenture holders and their agents (Josephthal) can milk the stock. Everyone who is invested in this stock should read the securities filings to see the exact terms -- when it was signed and when conversion can take place as well as the deal will be accounted for in the financials. Ideally, a company which has respect for its shareholders should explain all these details. The press release was a first positive step, but more details are needed. I wish all BLSI fans well - yet expect a few bumps in the road. Regards, Joe